Invesco Ltd. Has $630.81 Million Stock Holdings in Corteva, Inc. (NYSE:CTVA)

Invesco Ltd. raised its holdings in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 2.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,074,633 shares of the company's stock after acquiring an additional 264,531 shares during the quarter. Invesco Ltd. owned approximately 1.61% of Corteva worth $630,811,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in CTVA. Flagship Wealth Advisors LLC purchased a new position in Corteva in the fourth quarter valued at about $25,000. Noble Wealth Management PBC bought a new stake in shares of Corteva in the 4th quarter valued at approximately $26,000. Hager Investment Management Services LLC acquired a new position in Corteva in the fourth quarter worth approximately $27,000. Golden State Wealth Management LLC bought a new position in Corteva during the fourth quarter valued at approximately $32,000. Finally, Centricity Wealth Management LLC acquired a new stake in Corteva in the fourth quarter valued at approximately $34,000. Institutional investors and hedge funds own 81.54% of the company's stock.

Corteva Price Performance

Corteva stock traded up $1.33 during mid-day trading on Friday, hitting $59.27. 3,067,223 shares of the company were exchanged, compared to its average volume of 3,306,914. The company has a market capitalization of $40.48 billion, a PE ratio of 45.95, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The business has a fifty day moving average of $61.27 and a 200 day moving average of $60.25. Corteva, Inc. has a 1-year low of $50.01 and a 1-year high of $66.24. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08.

Remove Ads

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, sell-side analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were given a dividend of $0.17 per share. The ex-dividend date was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a yield of 1.15%. Corteva's dividend payout ratio (DPR) is presently 52.71%.

Insider Activity at Corteva

In other Corteva news, insider Brian Titus sold 26,560 shares of the business's stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the transaction, the insider now directly owns 11,347 shares of the company's stock, valued at approximately $723,257.78. The trade was a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.14% of the company's stock.

Analysts Set New Price Targets

CTVA has been the topic of a number of recent research reports. Oppenheimer raised their price target on shares of Corteva from $70.00 to $72.00 and gave the company an "outperform" rating in a report on Friday, February 7th. BNP Paribas upgraded shares of Corteva to a "hold" rating in a report on Monday, February 10th. The Goldman Sachs Group began coverage on shares of Corteva in a research report on Thursday, March 13th. They set a "buy" rating and a $71.00 target price on the stock. UBS Group dropped their price objective on shares of Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a report on Friday, January 10th. Finally, Argus upgraded shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 target price for the company in a research note on Monday, March 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, Corteva has a consensus rating of "Moderate Buy" and an average target price of $68.06.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.